Cargando…

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA(®) in Chinese healthy male subjects

Background: This study aimed to investigate the pharmacokinetics, safety, and immunogenicity of recombinant humanized anti-human IL-6R monoclonal antibody injection, LZM008, and evaluate the pharmacokinetic similarity between LZM008 and tocilizumab (ACTEMRA(®)) in Chinese healthy male subjects. Rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Guoying, Wang, Jingjing, He, Jinjie, Hu, Yingying, Yang, Haijing, Que, Linling, Gu, Xianghong, Yu, Jicheng, Wu, Xiaojie, Wu, Jufang, Fang, Wei, He, Qing, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110837/ https://www.ncbi.nlm.nih.gov/pubmed/37081963 http://dx.doi.org/10.3389/fphar.2023.1111893

Ejemplares similares

A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra(®)) in Chinese healthy subjects
por: Zhang, Hong, et al.
Publicado: (2021)

A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects
por: Cao, Guoying, et al.
Publicado: (2020)

Phase I study of LZM005 in patients with HER2-positive metastatic breast cancer
por: Xue, Cong, et al.
Publicado: (2022)

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men
por: Zhang, Hong, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
por: Li, Shanshan, et al.
Publicado: (2023)

Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab
por: Miao, Shiwei, et al.
Publicado: (2017)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
por: Hu, Yingying, et al.
Publicado: (2023)

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system
por: An, Qing, et al.
Publicado: (2019)

A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
por: Wang, Jin, et al.
Publicado: (2019)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects
por: Qian, Hongjie, et al.
Publicado: (2023)

Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
por: Doevendans, Erik, et al.
Publicado: (2019)

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
por: Huang, Kai, et al.
Publicado: (2021)

Hadron calorimeter of ATLAS 008
por: Chernykh, S, et al.
Publicado: (1994)

A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects
por: Yang, Haijing, et al.
Publicado: (2023)

008 se va con la murga
por: Campoamor, María José
Publicado: (1986)

AB008. Management of fertility post cancer
por: Smith, James
Publicado: (2016)

AB008. Treatment of retroperitoneoscopic adrenalectomy for pheochromocytoma
por: Li, Zeliang
Publicado: (2017)

Pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
por: Wessels, Hendrik, et al.
Publicado: (2019)

Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysis
por: Yang, Li-Jou, et al.
Publicado: (2022)

Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis
por: Wu, Hailan, et al.
Publicado: (2021)

P02-008 - Dramatic response to canakinumab in MKD
por: Makay, B, et al.
Publicado: (2013)

PW03-008 – Mitochondrial disturbances in Schnitzler syndrome
por: Sediva, A, et al.
Publicado: (2013)

PW01-008 – The inflammasome and secretory pathways in FMF
por: Orak, B, et al.
Publicado: (2013)

P03-008 - Gastrointestinal involvement in Behçet’s syndrome
por: Hatemi, I, et al.
Publicado: (2013)

Development of Streptomyces sp. FR-008 as an emerging chassis()
por: Liu, Qian, et al.
Publicado: (2016)

Complete Genome Sequence of Vibrio coralliilyticus OCN008
por: Lydick, Victoria N., et al.
Publicado: (2020)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
por: Roth, Karsten, et al.
Publicado: (2019)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
por: Wang, Yu, et al.
Publicado: (2022)

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
por: Talotta, Rossella, et al.
Publicado: (2017)

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
por: Barbier, Liese, et al.
Publicado: (2020)

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis
por: Alten, Rieke, et al.
Publicado: (2020)

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
por: Kurki, Pekka, et al.
Publicado: (2021)

P01-008 – FMF genotype-phenotype correlations in Germany
por: Jeske, M, et al.
Publicado: (2013)

PW02-008 - TRAPS in the real world: an international registry
por: Lachmann, HJ, et al.
Publicado: (2013)

PSAT008 Pheochromocytoma Management: Considerations for Cardiac Stress Testing
por: Gandhi, Shriya, et al.
Publicado: (2022)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Yi, et al.
Publicado: (2023)

O008 Refining the Hypoxic Burden Algorithm by Investigating different Methods for Calculating the SpO2 Baseline
por: He, S, et al.
Publicado: (2023)

Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira(®) in healthy subjects
por: Hyland, Elizabeth, et al.
Publicado: (2016)

Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_reqtm8qf8a0dhtp8rdv22cosk6